Brief: Redcare Pharmacy Says Total Sales Up 27% To 1.4 billion Euros In H1
29/07/2025 05:35
July 29 (Reuters) - Redcare Pharmacy NV RDC.DE: EQS-NEWS: REDCARE PHARMACY’S ADJUSTED EBITDA MARGIN IN Q2 AT A 12-MONTH HIGH OF 2.6%, WITH CONTINUED STRONG SALES GROWTH OF 26.5%. REDCARE PHARMACY Q2 NET INCOME EUR 8.9 MILLION REDCARE PHARMACY NV - TOTAL SALES UP 27% TO EUR 1.4BN IN H1 REDCARE PHARMACY NV - GUIDANCE FOR FULL YEAR 2025 IS UNCHANGED REDCARE PHARMACY NV - ADJ. EBITDA MARGIN 2.6% IN Q2 OR EUR 18M Source text: [ID:] Further company coverage: RDC.DE ((Reuters.Briefs@thomsonreuters.com;))